| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Australia | 2 | |
| #2 | Canada | 2 | |
| #3 | China | 2 | |
| #4 | EPO (European Patent Office) | 2 | |
| #5 | Mexico | 2 | |
| #6 | Poland | 2 | |
| #7 | United States | 2 | |
| #8 | EAPO (Eurasian Patent Organization) | 1 | |
| #9 | Hong Kong | 1 | |
| #10 | Hungary | 1 | |
| #11 | Israel | 1 | |
| #12 | Japan | 1 | |
| #13 | New Zealand | 1 | |
| #14 | WIPO (World Intellectual Property Organization) | 1 |
| # | Industry | |
|---|---|---|
| #1 | Organic fine chemistry | |
| #2 | Pharmaceuticals |
| # | Name | Total Patents |
|---|---|---|
| #1 | Alken Rudolf-Giesbert | 15 |
| #2 | Alken Rudolf-Gisbert | 2 |
| #3 | Stabingis Thomas | 2 |
| #4 | Perrone Alessia | 1 |
| #5 | Rudolf-Giesbert Alken | 1 |
| #6 | Thomas Alken Rudolf-Giesbert S | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO2019073045A1 | Use of no donors | |
| CA2513077A1 | Use of l-dopa, derivatives thereof and medicaments comprising said compounds for the prophylaxis of psychotic diseases | |
| CA2513088A1 | Deuterated catecholamine derivatives and medicaments comprising said compounds |